share_log

石藥集團:自願公告 - 抗體藥物偶聯物SYS6023獲臨床試驗批准

CSPC PHARMA: VOLUNTARY ANNOUNCEMENT - ANTIBODY-DRUG CONJUGATE SYS6023 OBTAINS CLINICAL TRIAL APPROVAL

香港交易所 ·  Mar 20 05:25
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more